Clinical Trials Directory

Trials / Completed

CompletedNCT02031913

Prospective Cohort Study of Association of Insulin Resistance/Steatosis With Hepatic Fibrosis in CHB and NAFLD

Association Between Insulin Resistance and Hepatic Fibrosis in Combined Chronic Hepatitis B and Non-alcoholic Fatty Liver Disease

Status
Completed
Phase
Study type
Observational
Enrollment
500 (actual)
Sponsor
Seoul National University Boramae Hospital · Academic / Other
Sex
All
Age
20 Years – 80 Years
Healthy volunteers
Not accepted

Summary

Hepatic steatosis and insulin resistance are associated with severity of fibrosis in non-alcoholic fatty liver disease (NAFLD) and chronic hepatitis C. However, clinical significance of steatosis and insulin resistance on fibrosis in chronic hepatitis B (CHB) is not well established. The aim was to investigate the relationship between insulin resistance, hepatic steatosis, and fibrosis in patients with CHB.

Detailed description

acoustic radiation force impulse elastography

Conditions

Timeline

Start date
2013-01-01
Primary completion
2022-11-01
Completion
2022-12-01
First posted
2014-01-09
Last updated
2023-04-12

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT02031913. Inclusion in this directory is not an endorsement.